Beximco Pharmaceuticals (BXP) Stock Chart & Stock Price History GBX 45.62 -0.88 (-1.89%) As of 09/5/2025 07:37 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesBuy This Stock Beximco Pharmaceuticals Stock Price Performance The Beximco Pharmaceuticals (BXP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 105.50%, with a year-to-date return of 19.42%. In the past month, the stock has increased 1.38%, reflecting recent market activity. As of the latest close, Beximco Pharmaceuticals traded at GBX 45.62 with a market cap of £203.52 million and volume of 6,165 shares. Five years ago, the stock traded at GBX 62.50, representing a 27.01% decrease over that period. At the time, it had a market cap of £253.47 million and a volume of 163,345 shares. Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.67%1 Month Performance+1.38%3 Month Performance+22.21%Year-To-Date Performance+19.42%1 Year Performance+105.50%5 Year Performance-27.01% BXP Stock Chart for Saturday, September, 6, 2025 BXP Chart by TradingView Beximco Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/05/2025GBX 46.50GBX 45.62-1.89%GBX 46.50GBX 45.626,165 shs£203.52 million09/04/2025GBX 46.50GBX 46.50GBX 48GBX 45.5650,480 shs£207.44 million09/03/2025GBX 46.87GBX 46.50-0.79%GBX 48GBX 45.5650,480 shs£207.44 million09/02/2025GBX 48GBX 46.87-2.35%GBX 46.87GBX 46.501,000 shs£209.09 million09/01/2025GBX 46.87GBX 48+2.41%GBX 48GBX 46.5080,000 shs£214.13 million08/29/2025GBX 46.11GBX 46.87+1.65%GBX 48GBX 46.1683,699 shs£31.95 billion08/28/2025GBX 48.67GBX 46.11-5.25%GBX 50.50GBX 46.1169,296 shs£31.43 billion08/27/2025GBX 50GBX 48.67-2.67%GBX 51.89GBX 48.6729,847 shs£33.17 billion08/26/2025GBX 49.60GBX 50+0.81%GBX 52.33GBX 5029,275 shs£34.08 billion08/25/2025GBX 49.60GBX 49.60GBX 50GBX 49.606,942 shs£33.81 billion Get the Latest News and Ratings for BXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 08/22/2025GBX 49.60GBX 49.60GBX 50GBX 49.606,942 shs£33.81 billion08/21/2025GBX 49.87GBX 49.60-0.54%GBX 51.98GBX 49.6029,632 shs£33.81 billion08/20/2025GBX 49.98GBX 49.87-0.22%GBX 49.87GBX 48.2671,725 shs£33.99 billion08/19/2025GBX 48.90GBX 49.98+2.21%GBX 49.98GBX 4970,038 shs£34.07 billion08/18/2025GBX 47.11GBX 48.90+3.80%GBX 49GBX 48.4248,491 shs£33.33 billion08/15/2025GBX 48.40GBX 47.11-2.67%GBX 47.50GBX 47.1151,687 shs£32.11 billion08/14/2025GBX 47GBX 48.40+2.98%GBX 48.89GBX 4657,688 shs£32.99 billion08/13/2025GBX 48.45GBX 47-2.99%GBX 48.45GBX 4726,539 shs£32.04 billion08/12/2025GBX 47GBX 48.45+3.09%GBX 48.45GBX 47.5011,225 shs£33.03 billion08/11/2025GBX 44.50GBX 47+5.62%GBX 48GBX 44.60151,732 shs£32.04 billion08/08/2025GBX 45GBX 45GBX 45GBX 43.5519,976 shs£30.68 billion08/07/2025GBX 45GBX 45GBX 45GBX 43.5519,976 shs£30.68 billion08/06/2025GBX 45GBX 45GBX 45GBX 42.3314,848 shs£30.68 billion08/05/2025GBX 40GBX 45+12.50%GBX 45GBX 38.89183,946 shs£30.68 billion Related Companies Molten Ventures Stock Chart Pinewood Technologies Group Stock Chart Prs Reit Stock Chart Saga Stock Chart Aurora Investment Trust Stock Chart Triple Point Social Housing REIT Stock Chart AdvancedAdvT Stock Chart Celtic Stock Chart Value and Indexed Property Income Stock Chart Corero Network Security Stock Chart Receive BXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BXP) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
